STAT

JULY 25, 2023

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal.

228

228

Pharma Mirror

APRIL 21, 2024

The post Exploring Periodontal Disease: Present Therapies, Emerging Treatments, and Beyond appeared first on Pharma Mirror Magazine. Untreated Periodontitis ultimately results in tooth loss, chronic inflammation, and pain. There are also a variety of systemic health effects linked to the disease which are even more detrimental.

52

52

World Pharma News

MARCH 4, 2024

Novartis today presented new data that continue to support the clinical benefits of Zolgensma® (onasemnogene abeparvovec), the only one-time gene therapy for the treatment of spinal muscular atrophy (SMA). Final data from the SMART study highlight the safety and efficacy profile of Zolgensma in children with SMA weighing ≥ 8.5

80

80

STAT

DECEMBER 20, 2023

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke. He is also trying to fight the long legacy of racism in neuroscience.

235

235

RX Note

JUNE 25, 2023

If and only if I know how to engage with audience, why would I search how to do a good presentation? Instead of finding out how to make a marvellous presentation, why not start thinking What do we expect when we are the audience ? Not all information has to be included in CME presentation slide.

40

40

European Pharmaceutical Review

OCTOBER 30, 2023

At present, there are no curative treatments for LGMD2I/R9. Additionally, these first results were also presented at the 2023 International Limb-Girdle Muscular Dystrophy Conference. According to Atamyo Therapeutics, the condition is characterised by progressive muscular weakness, leading to loss of the ability to walk independently.

88

88

European Pharmaceutical Review

JULY 8, 2022

In an article published in the Journal of Validation Technology (JVT), pharmaceutical microbiologist and contamination control expert Tim Sandle identified ten categories of risk presented by aging. Degradation of the facilities, for instance cracks in walls or tears in material, can also present contamination challenges.

122

122

Safe Biologics

MARCH 30, 2023

The recently-published Executive Summary from the 75th INN Consultation, at which ASBM presented in October 2022, summarizes ASBM’s position regarding the value of distinct biologic nomenclature: One significant challenge to efficient global cooperation is the lack of harmonization.

Biosimilars 100

Biosimilars Labelling 100

pharmaphorum

APRIL 17, 2024

Discover how AI is transforming medical communications and reshaping the future of healthcare. Learn about the latest trends, technologies, and advancements in this rapidly evolving field.

Communication 108

Communication 108

European Pharmaceutical Review

SEPTEMBER 7, 2023

The post Alzheimer’s senescent cell combination therapy presents promise appeared first on European Pharmaceutical Review. A larger $3 million, Phase II clinical trial is in process, with the aim to test the effects of clearing senescent cells with the combination therapy, the paper noted.

96

96

Outsourcing Pharma

NOVEMBER 29, 2021

The biotech firm has presented data from a study that could offer hope to patients with Parkinsonâs, Gaucher, Alzheimerâs and other neurodegenerative conditions.

114

114

Express Pharma

SEPTEMBER 10, 2023

Results presented from the Phase III IMpower133 study and extension trial IMbrella A, show Roche’s Tecentriq (atezolizumab), in combination with chemotherapy, demonstrates a potential long-term overall survival (OS) benefit as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC). Presented at WCLC 2023.

Chemotherapy 100

Chemotherapy 100

pharmaphorum

JUNE 7, 2022

This post makes a case for encouraging and supporting presenters in order to get the most out of their expertise. You’ve been invited to deliver a presentation. Presentation success is a ‘team sport’. Before you know it, your presentation is completely off the rails. Does your topic require a presentation?

Communication 93

Communication 93

STAT

FEBRUARY 17, 2024

DENVER — The GLP-1 medication liraglutide significantly reduced opioid cravings in a small analysis presented on Saturday. It is the first randomized controlled trial to test anti-obesity drugs against opioid addiction, which kills around 80,000 people in the U.S. Read the rest…

361

361

PharmaTech

APRIL 2, 2024

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body’s cancer-immune cycle. When the system is in good working order (and protecting us), dead cancer cells release neoantigens.

Immunity 52

Immunity Immunization 52

Pharmaceutical Commerce

DECEMBER 18, 2023

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

103

103

Pharmaceutical Technology

NOVEMBER 7, 2023

At AAO 2023, results were presented from the Phase IIa trial of Allgenesis’ AG-73305, evaluating its application for the treatment of DME.

59

59

Viseven

NOVEMBER 6, 2023

The post Viseven Presents New Brand Identity: Reflecting Transformation appeared first on Viseven. The company’s solutions, products, and services are actively used by the TOP 100 Pharma and Life Sciences companies in more than 50 countries around the globe. Follow Viseven on social media: LinkedIn , Twitter, YouTube , and Facebook.

Communication 64

Communication 64

Find Your Script

JUNE 4, 2022

Purchase Pharmacy Poster Presentation Templates here! The post How to Make a Pharmacy Poster Presentation appeared first on Find Your Script by Dr. Jessica Louie. We talk passive income and simplifying on this channel to combat stress and burnout. What to include? How to format it? Link to purchase. Best step to take? How to print it?

52

52

ALiEM - Pharm Pearls

MARCH 18, 2024

A 30-year-old female with a past medical history of Crohn’s Disease presented to the ED for evaluation of an acutely bruised right 4th finger. She stated she was typing on a computer keyboard approximately 10 minutes prior to presentation and she noticed a sudden popping sensation at the base of her right ring finger.

300

300

Pharmacy Times

DECEMBER 11, 2023

The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.

52

52

Express Pharma

APRIL 17, 2023

Bugworks Research will present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. Bugworks Research’s presentations will take place on April 13, 2023, during the poster session.

52

52

European Pharmaceutical Review

AUGUST 25, 2022

The post Oncolytic viruses: past and present appeared first on European Pharmaceutical Review. human study of TK?positive positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells. J Transl med. 2019;17:271.

Immunity 98

Immunity Immunization Chemotherapy Packaging 98

STAT

JANUARY 9, 2024

The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P. ” When Kimberly Powell, Nvidia’s vice president of health care, finished her presentation, the room erupted in applause.

347

347

STAT

OCTOBER 21, 2023

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday. The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Chemotherapy 338

Chemotherapy Drug Development 338

STAT

MARCH 22, 2024

That’s what attendees at the Breakthrough Summit East in New York had on their hands Thursday, as four participants presented their work in this year’s STAT Madness competition — an annual March Madness bracket-style battle to find the best innovation in science and medicine. A little madness. Read the rest…

315

315

World Pharma News

OCTOBER 9, 2023

NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2023 held in Boston from October 11-15, 2023. Pfizer Inc. Data from 45 abstracts will highlight the advances Pfizer is making in helping prevent and treat certain infectious diseases, particularly respiratory illnesses.

Vaccines 79

Vaccines Immunity Immunization 79

Pharmafile

APRIL 17, 2023

Published date: 17/04/2023 Summary: Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today presented updated interim clinical efficacy data including subgroup analyses of first-line pancreatic cancer (PDAC) patients treated with the antibody nadunolimab (CAN04) and chemotherapy in the phase I/IIa CANFOUR trial. months; p=0.017).

Chemotherapy 52

Chemotherapy 52

STAT

OCTOBER 25, 2023

A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler, under-the-skin injection is equally effective as the currently approved intravenous infusion, according to study results presented Wednesday by its maker, Eisai.

315

315

Express Pharma

MAY 25, 2023

The post Parkinson’s unmet needs present significant opportunity for new entrants: GlobalData appeared first on Express Pharma.

Compounding 92

Compounding Labelling 92

pharmaphorum

DECEMBER 5, 2022

A vast majority of patients diagnosed with CRPC already present with metastases at the time of diagnosis. The findings will be presented at an upcoming medical meeting and submitted to the FDA for regulatory approval in 2023. Prostate cancer is the most frequently diagnosed cancer in men in 112 countries.

Chemotherapy 58

Chemotherapy Compounding Labelling Drug Development 58

STAT

NOVEMBER 2, 2023

These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark. Continue to STAT+ to read the full story…

313

313

Pharmafile

MARCH 1, 2023

Chief Innovation and Strategy Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14th, at 4:05pm EDT. Chief Innovation and Strategy Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14th, at 4:05pm EDT. read more

40

40

Outsourcing Pharma

SEPTEMBER 16, 2020

A leader from Iqvia will present an overview of artificial intelligence, machine learning and other technology during this yearâs CPhI Festival of Pharma.

72

72

PharmaTech

FEBRUARY 15, 2024

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

52

52

Pharmacy Times

FEBRUARY 20, 2024

Certain patients may present asymptomatically, affecting treatment options.

26

26

STAT

JANUARY 29, 2024

Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the condition. LONDON — There was something odd about these Alzheimer’s cases. But it was also that the patients were in their 40s and 50s, even their 30s, far younger than people who normally develop the disease.

Documentation 364

Documentation 364